Corcept Therapeutics Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2018 | $35.8M | $311.7M | $41.6M |
| FY2019 | $41.1M | $412.3M | $31.3M |
| FY2020 | $48.4M | $571.7M | $76.2M |
| FY2021 | $48.0M | $423.8M | $77.6M |
| FY2022 | $81.6M | $583.4M | $66.3M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2018 | $35.8M | $311.7M | $41.6M |
| FY2019 | $41.1M | $412.3M | $31.3M |
| FY2020 | $48.4M | $571.7M | $76.2M |
| FY2021 | $48.0M | $423.8M | $77.6M |
| FY2022 | $81.6M | $583.4M | $66.3M |